Ph.D., Department of Operations Management and Information Technology
Dissertation title: Process innovation in the pharmaceutical industry Supervisor: Professor Dimitrios ANDRITSOS
Master Degree in Economics of an Enterprise. GPA 4.9/5.0
Specialist in Foreign Economic Activity. GPA 5.0/5.0
“Process innovation in the pharmaceutical industry” (with Dimitris Andritsos and Claire Senot): invited to revise and re-submit at Manufacturing & Service Operations Management.
“Novelty and scope of innovation in manufacturing: The role of related and unrelated production experience” (with Dimitris Andritsos and Claire Senot)
“Process innovation and the longevity of its economic effects” (with Dimitris Andritsos)
“Buying generic drugs through a tender process: Empirical insights into the purchasing practices of health-insurance companies” (with Jürgen Mihm)
Operations and Technology Management (Executive MBA): Spring 2018, Spring 2019
Operations and Technology Management (Full-Time MBA): Fall 2016, Spring 2017, Spring 2018, Spring 2019
Supply chain management (MSc): Fall 2014, Spring 2017, Spring 2018
Title: “Process innovation in the pharmaceutical industry”
INFORMS Annual 2019 (Seattle), INFORMS Healthcare 2019 (Boston), R&D management conference 2019 (Paris), S&O day 2019 (Jouy-en-Josas), TADC 2019 (London), POMS Annual 2019 (Washington), INFORMS Annual 2018 (Phoenix), AOM Annual 2018 (Chicago), ETOM day 2018 (Fontainebleau), INFORMS Healthcare 2017 (Rotterdam), INFORMS Annual 2017 (Houston), ROLAND GARROS HEC Foundation event 2017 (Paris)
Title: “Determinants of process innovation”
INFORMS Annual 2019 (Seattle), INFORMS Healthcare 2019 (Boston), POMS Annual 2019 (Washington)
Distributor of Active Pharmaceutical Ingredients and Final Dosage Forms
Board member / CEO
Started affiliate company in Schaffhausen, Switzerland
Developed the business in Germany, selected an acquisition target, performed cost structure analysis.
Recruited the executive team and coordinated the financing process.
Full responsibility for the development of the product portfolio and the manufacturing infrastructure.
Synbias Pharma Ltd / Ukraine-France-Germany /
Production and sale of anticancer Active Pharmaceutical Ingredients
Improved the existing supply chain, doubling sales in 2 years.
Created the distribution network of final dosage forms in 5 EU countries.
Developed business plans and organized financing for several manufacturing projects. Achieved the manufacturing costs decrease of 12%
Developed business plans, organized financing and launched operations for clients in the telecommunications, agriculture and retail industries.
English (Fluent), Russian (Native), Ukrainian (Native), French (B1), German (B1)
Professor Dimitrios Andritsos
1 Rue de la Libération
Professor Claire Senot
Tulane University. Freeman School of Business
7 McAlister Dr.
New Orleans, LA 70118
Professor Jürgen Mihm
Boulevard de Constance
Professor Svenja Sommer
1 Rue de la Libération
Professor Sven Riethmueller
Yale Law School
127 Wall Street
New Haven, CT 06511